Abstract
Through labelling of cells with magnetic contrast agents it is possible to follow the fate of transplanted cells in vivo with magnetic resonance imaging (MRI) as has been demonstrated in animal studies as well as in a clinical setting. A large variety of labelling strategies are available that allow for prolonged and sensitive detection of the labelled cells with MRI. The various protocols each harbour specific advantages and disadvantages. In choosing a particular labelling strategy it is also important to ascertain that the labelling procedure does not negatively influence cell functionality, for which a large variety of assays are available. In order to overcome the challenges still faced in fully exploiting the benefits of in vivo cell tracking by MRI a good understanding and standardisation of the procedures and assays used will be crucial.
Original language | English |
---|---|
Pages (from-to) | 255-274 |
Number of pages | 20 |
Journal | European Radiology |
Volume | 20 |
Issue number | 2 |
DOIs | |
Publication status | Published - Feb 2010 |
Bibliographical note
Funding Information:The authors would like to acknowledge and thank Dr. Eric Farrell for supplying pictures on differentiated labeled stem cells. This paper has been written in part through support from ENCITE - funded by the European Community under the 7th Framework program.
Research programs
- EMC NIHES-03-30-03